Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Jan;67(1):141–148. doi: 10.1172/JCI110006

Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase.

J J Albers, J L Adolphson, C H Chen
PMCID: PMC371581  PMID: 6778896

Abstract

A sensitive and precise competitive-displacement double-antibody radioimmunoassay was developed for the human plasma enzyme lecithin-cholesterol acyltransferase (LCAT; Ec 2.3 1.43). The ability of plasma from various animal species to displace labeled human LCAT from goat anti-human LCAT could be ranked in the following order: man and sheep > nonhuman primates > cat or dog > pig > rabbit or guinea pig > mouse > rat. Normolipidemic subjects had levels of LCAT of 6.14 +/- 0.98 micrograms/ml (mean +/- SD, n = 66). Subjects with dysbeta-lipoproteinemia had the highest plasma LCAT levels (7.88 +/- 0.39 micrograms/ml, n = 7, P < 0.05), followed by hypercholesterolemic subjects (7.00 +/- 1.30, n = 41) and hypertriglyceridemic subjects (6.96 +/- 1.3, n = 10). LCAT-deficient subjects had the lowest enzyme levels (0.89, 0.83, and 0.05 micrograms/ml, respectively, and two subjects with no detectable enzyme). Males had lower LCAT levels (6.42 +/- 1.05 micrograms/ml, n = 90, for all subjects; 5.99 +/- 1.03, n = 44, for normolipidemics) than females (7.01 +/- 1.14, n = 34, for all subjects P < 0.01; 6.44 +/- 0.79, n = 22, for normolipidemics, P < 0.01). LCAT levels correlated significantly with total cholesterol (males, r = 0.384, P < 0.001; females, r = 0.519, P < 0.002); and total triglyceride (only in females, r = 0.512, P < 0.002). LCAT levels in females correlated inversely with HDL cholesterol (r = 0.341, P < 0.05) and apoprotein D (r = 0.443, P < 0.02), but no such relationship existed in males.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Cabana V. G., Dee Barden Stahl Y. Purification and characterization of human plasma lecithin:cholesterol acyltransferase. Biochemistry. 1976 Mar 9;15(5):1084–1087. doi: 10.1021/bi00650a020. [DOI] [PubMed] [Google Scholar]
  2. Albers J. J. Effect of human plasma apolipoproteins on the activity of purified lecithin:cholesterol acyltransferase. Scand J Clin Lab Invest Suppl. 1978;150:48–52. [PubMed] [Google Scholar]
  3. Albers J. J., Lin J., Roberts G. P. Effect of human plasma apolipoproteins on the activity of purified lecithin: cholesterol acyltransferase. Artery. 1979 Jan;5(1):61–75. [PubMed] [Google Scholar]
  4. Albers J. J., Scanu A. M. Isoelectric fractionation and characterization of polypeptides from human serum very low density lipoproteins. Biochim Biophys Acta. 1971 Apr 27;236(1):29–37. doi: 10.1016/0005-2795(71)90145-0. [DOI] [PubMed] [Google Scholar]
  5. Albers J. J., Wahl P. W., Cabana V. G., Hazzard W. R., Hoover J. J. Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism. 1976 Jun;25(6):633–644. doi: 10.1016/0026-0495(76)90060-3. [DOI] [PubMed] [Google Scholar]
  6. Cheung M. C., Albers J. J. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest. 1977 Jul;60(1):43–50. doi: 10.1172/JCI108767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  8. Frohlich J., Godolphin W. J., Reeve C. E., Evelyn K. A. Familial LCAT deficiency. Report of two patients from a Canadian family of Italian and Swedish descent. Scand J Clin Lab Invest Suppl. 1978;150:156–161. [PubMed] [Google Scholar]
  9. GILMAN A. M., NISONOFF A., DRAY S. SYMMETRICAL DISTRIBUTION OF GENETIC MARKERS IN INDIVIDUAL RABBIT GAMMA-GLOBULIN MOLECULES. Immunochemistry. 1964 Jun;1:109–120. doi: 10.1016/0019-2791(64)90075-8. [DOI] [PubMed] [Google Scholar]
  10. GLOMSET J. A., WRIGHT J. L. SOME PROPERTIES OF A CHOLESTEROL ESTERIFYING ENZYME IN HUMAN PLASMA. Biochim Biophys Acta. 1964 Aug 26;89:266–276. doi: 10.1016/0926-6569(64)90215-9. [DOI] [PubMed] [Google Scholar]
  11. Glomset J. A., Norum K. R. The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res. 1973;11:1–65. [PubMed] [Google Scholar]
  12. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  13. Hamnström B., Gjone E., Norum K. R. Familial plasma lecithin: cholesterol acyltransferase deficiency. Br Med J. 1969 May 3;2(5652):283–286. doi: 10.1136/bmj.2.5652.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hubbard A. L., Cohn Z. A. The enzymatic iodination of the red cell membrane. J Cell Biol. 1972 Nov;55(2):390–405. doi: 10.1083/jcb.55.2.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Lacko A. G., Rutenberg H. L., Soloff L. A. The influence of age and sex on the esterification of human serum cholesterol. Biochem Med. 1977 Jun;17(3):275–283. doi: 10.1016/0006-2944(77)90033-3. [DOI] [PubMed] [Google Scholar]
  17. Marcel Y. L., Vezina C. A method for the determination of the initial rate of reaction of lecithin: cholesterol acyltransferase in human plasma. Biochim Biophys Acta. 1973 Jun 21;306(3):497–504. doi: 10.1016/0005-2760(73)90188-4. [DOI] [PubMed] [Google Scholar]
  18. McConathy W. J., Alaupovic P. Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett. 1973 Dec 1;37(2):178–182. doi: 10.1016/0014-5793(73)80453-3. [DOI] [PubMed] [Google Scholar]
  19. Nordby G., Norum K. R. Aspects of the role of lecithin:cholesterol acyltransferase in metabolism of triglycerides. Scand J Clin Lab Invest Suppl. 1978;150:111–114. [PubMed] [Google Scholar]
  20. Patsch W., Lisch H. J., Sailer S., Braunsteiner H. Initial cholesterol esterification rate in hyperlipoproteinaemia: effects of triglyceride-rich lipoproteins. Eur J Clin Invest. 1978 Aug;8(4):209–213. doi: 10.1111/j.1365-2362.1978.tb00854.x. [DOI] [PubMed] [Google Scholar]
  21. Schenkein I., Levy M., Uhr J. W. The use of glucose oxidase as a generator of H 2 O 2 in the enzymatic radioiodination of components of cell surfaces. Cell Immunol. 1972 Nov;5(3):490–493. doi: 10.1016/0008-8749(72)90076-7. [DOI] [PubMed] [Google Scholar]
  22. Subbaiah P. V., Albers J. J., Chen C. H., Bagdade J. D. Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase. J Biol Chem. 1980 Oct 10;255(19):9275–9280. [PubMed] [Google Scholar]
  23. Wallentin L., Angelin B., Einarsson K., Leijd B. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects. Scand J Clin Lab Invest Suppl. 1978;150:103–110. [PubMed] [Google Scholar]
  24. Warnick G. R., Mayfield C., Albers J. J., Hazzard W. R. Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. Clin Chem. 1979 Feb;25(2):279–284. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES